GBA1 and Parkinson disease: E326K, E388K, and T369M GBA1 mutations do not cause GD but have been specifically associated with an increased risk (i.e., “risk” variants) of developing aggressive α-synucleinopathies, such as PD and dementia with Lewy bodies.